AxoProtego Therapeutics

axoprotego.com
6958 Aviation Blvd., Suite H
Glen Burnie, MD 21061

Company Info

Phone
(415) 317-2034

Year Established
2018

Contacts

Richard A. Moran, PhD
CEO

Company Description

AxoProtego Therapeutics is committed to individuals worldwide who suffer from, or are at risk for, “peripheral neuropathy”—a type of nerve damage that results in weakness, numbness, pain, or tingling, usually in the hands or feet. There are many causes of peripheral neuropathy. Their initial focus is neuropathy caused by chemotherapy, also known as Chemotherapy-Induced Peripheral Neuropathy (CIPN).